Skip to Main Content
DownloadHi-Res Photo

Lauren A. Baldassarre, MD, FACC

Associate Professor; Vice Chief of Diversity, Equity and Inclusion, Cardiovascular Medicine; Director, Cardio-Oncology, Cardiovascular Medicine

Contact Information

Lauren A. Baldassarre, MD, FACC

Mailing Address

  • Cardiovascular Medicine

    15 York Street, PO Box 208017

    New Haven, CT 06520-8017

    United States

Related Links

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Coauthors

Selected Publications

  • Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis.Sharp MB, Soufer A, Abdelmessih M, Rosenfeld LE, Baldassarre LA, Miller EJ. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2020, 27: 688-690 PubMed ID: 30737635, DOI: 10.1007/s12350-019-01640-z.
  • Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods.Soufer A, Liu C, Henry ML, Baldassarre LA. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2020, 27: 1210-1224 PubMed ID: 30868378, DOI: 10.1007/s12350-019-01671-6.
  • Valvular imaging in the era of feature-tracking: A slice-following cardiac MR sequence to measure mitral flow.Seemann F, Heiberg E, Carlsson M, Gonzales RA, Baldassarre LA, Qiu M, Peters DC. Valvular imaging in the era of feature-tracking: A slice-following cardiac MR sequence to measure mitral flow. Journal Of Magnetic Resonance Imaging : JMRI 2020, 51: 1412-1421 PubMed ID: 31654470, PMCID: PMC7217167, DOI: 10.1002/jmri.26971.
  • Opportunities for improved cardiovascular disease prevention in oncology patients.Bravo-Jaimes K, Marcellon R, Varanitskaya L, Kim PY, Iliescu C, Gilchrist SC, Baldassarre LA, Manisty C, Ghosh AK, Guha A, Lopez-Mattei JC. Opportunities for improved cardiovascular disease prevention in oncology patients. Current Opinion In Cardiology 2020, 35: 531-537 PubMed ID: 32649353, DOI: 10.1097/HCO.0000000000000767.
  • Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.Quail M, Grunseich K, Baldassarre LA, Mojibian H, Marieb MA, Cornfeld D, Soufer A, Sinusas AJ, Peters DC. Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance. Journal Of Cardiovascular Magnetic Resonance : Official Journal Of The Society For Cardiovascular Magnetic Resonance 2019, 21: 2 PubMed ID: 30602395, PMCID: PMC6317232, DOI: 10.1186/s12968-018-0514-3.
  • REPAIRit: Improving Myocardial Nulling and Ghosting Artifacts of 3D Navigator-Gated Late Gadolinium Enhancement Imaging During Arrhythmia.Hu C, Huber S, Latif SR, Santacana-Laffitte G, Mojibian HR, Baldassarre LA, Peters DC. REPAIRit: Improving Myocardial Nulling and Ghosting Artifacts of 3D Navigator-Gated Late Gadolinium Enhancement Imaging During Arrhythmia. Journal Of Magnetic Resonance Imaging : JMRI 2019, 49: 688-699 PubMed ID: 30252987, DOI: 10.1002/jmri.26284.
  • Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.Latif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy. The International Journal Of Cardiovascular Imaging 2019, 35: 1309-1318 PubMed ID: 30790116, DOI: 10.1007/s10554-019-01551-7.
  • The Role of Cardiac Magnetic Resonance Imaging to Detect Cardiac Toxicity From Cancer Therapeutics.Soufer A, Baldassarre LA. The Role of Cardiac Magnetic Resonance Imaging to Detect Cardiac Toxicity From Cancer Therapeutics. Current Treatment Options In Cardiovascular Medicine 2019, 21: 28 PubMed ID: 31104180, DOI: 10.1007/s11936-019-0732-5.
  • Presentation of Liver Failure From a Pericardial Mass.Nguyen VQ, Workman V, Stendahl K, Young L, Sklar J, Baldassarre LA. Presentation of Liver Failure From a Pericardial Mass. Circulation. Cardiovascular Imaging 2019, 12: e008672 PubMed ID: 31167559, DOI: 10.1161/CIRCIMAGING.118.008672.
  • Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate.Gallegos C, Rottmann D, Nguyen VQ, Baldassarre LA. Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate. European Heart Journal. Case Reports 2019, 3: yty149 PubMed ID: 31020225, PMCID: PMC6439394, DOI: 10.1093/ehjcr/yty149.
  • Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET).Higgins AY, Taylor EP, Baldassarre LA, Miller EJ, Rosenfeld LE. Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET). Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2018, 25: 1869-1871 PubMed ID: 29116563, DOI: 10.1007/s12350-017-1099-1.
  • Reverse double inversion-recovery: Improving motion robustness of cardiac T2 -weighted dark-blood turbo spin-echo sequence.Hu C, Huber S, Latif SR, Santacana-Laffitte G, Mojibian HR, Baldassarre LA, Peters DC. Reverse double inversion-recovery: Improving motion robustness of cardiac T2 -weighted dark-blood turbo spin-echo sequence. Journal Of Magnetic Resonance Imaging : JMRI 2018, 47: 1498-1508 PubMed ID: 29112315, PMCID: PMC6346424, DOI: 10.1002/jmri.25886.
  • Assessment of diastolic function and atrial remodeling by MRI - validation and correlation with echocardiography and filling pressure.Seemann F, Baldassarre LA, Llanos-Chea F, Gonzales RA, Grunseich K, Hu C, Sugeng L, Meadows J, Heiberg E, Peters DC. Assessment of diastolic function and atrial remodeling by MRI - validation and correlation with echocardiography and filling pressure. Physiological Reports 2018, 6: e13828 PubMed ID: 30187654, PMCID: PMC6125607, DOI: 10.14814/phy2.13828.
  • Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis.Hur DJ, Dicks DL, Huber S, Mojibian HR, Meadows JL, Seropian SE, Baldassarre LA. Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis. Circulation. Cardiovascular Imaging 2016, 9 PubMed ID: 27682238, DOI: 10.1161/CIRCIMAGING.116.004770.
  • Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.Baldassarre LA, Raman SV, Min JK, Mieres JH, Gulati M, Wenger NK, Marwick TH, Bucciarelli-Ducci C, Bairey Merz CN, Itchhaporia D, Ferdinand KC, Pepine CJ, Walsh MN, Narula J, Shaw LJ. Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. JACC. Cardiovascular Imaging 2016, 9: 421-35 PubMed ID: 27056162, PMCID: PMC5486953, DOI: 10.1016/j.jcmg.2016.01.004.
  • SCCT curriculum guidelines for general (level 1) cardiovascular CT training.Maroules CD, Cheezum MK, Joshi PH, Williams M, Simprini LA, Nelson KH, Bittencourt MS, Carr JJ, Weigold WG, Cury RC, Blankstein R, Abbara S. SCCT curriculum guidelines for general (level 1) cardiovascular CT training. Journal Of Cardiovascular Computed Tomography 2015, 9: 81-8 PubMed ID: 25708013, DOI: 10.1016/j.jcct.2015.01.004.
  • Imaging of the right heart--CT and CMR.Kochav J, Simprini L, Weinsaft JW. Imaging of the right heart--CT and CMR. Echocardiography (Mount Kisco, N.Y.) 2015, 32 Suppl 1: S53-68 PubMed ID: 25244072, DOI: 10.1111/echo.12212.
  • Routine cine-CMR for prosthesis-associated mitral regurgitation: a multicenter comparison to echocardiography.Simprini LA, Afroz A, Cooper MA, Klem I, Jensen C, Kim RJ, Srichai MB, Heitner JF, Sood M, Chandy E, Shah DJ, Lopez-Mattei J, Biederman RW, Grizzard JD, Fuisz A, Ghafourian K, Farzaneh-Far A, Weinsaft J. Routine cine-CMR for prosthesis-associated mitral regurgitation: a multicenter comparison to echocardiography. The Journal Of Heart Valve Disease 2014, 23: 575-82 PubMed ID: 25799706, PMCID: PMC5057384.
  • Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass.Simprini LA, Goyal P, Codella N, Fieno DS, Afroz A, Mullally J, Cooper M, Wang Y, Finn JP, Devereux RB, Weinsaft JW. Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass. Journal Of Hypertension 2013, 31: 2069-76 PubMed ID: 24107735, PMCID: PMC4017912, DOI: 10.1097/HJH.0b013e328362d935.
  • Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation.Chinitz JS, Chen D, Goyal P, Wilson S, Islam F, Nguyen T, Wang Y, Hurtado-Rua S, Simprini L, Cham M, Levine RA, Devereux RB, Weinsaft JW. Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation. JACC. Cardiovascular Imaging 2013, 6: 220-34 PubMed ID: 23489536, PMCID: PMC4048744, DOI: 10.1016/j.jcmg.2012.08.016.
  • The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project.Simprini LA, Villines TC, Rich M, Taylor AJ. The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project. Journal Of Clinical Lipidology 2012, 6: 174-9 PubMed ID: 22385551, DOI: 10.1016/j.jacl.2011.11.005.
  • Cardiac CT in women: clinical application and considerations.Simprini LA, Taylor AJ. Cardiac CT in women: clinical application and considerations. Journal Of Cardiovascular Computed Tomography 2012, 6: 71-7 PubMed ID: 22369778, DOI: 10.1016/j.jcct.2012.01.003.
  • Prospective evaluation of the updated 2010 ACCF Cardiac CT Appropriate Use Criteria.Rich ME, Utsunomiya D, Simprini LA, Weigold WG, Weissman G, Taylor AJ. Prospective evaluation of the updated 2010 ACCF Cardiac CT Appropriate Use Criteria. Journal Of Cardiovascular Computed Tomography 2012, 6: 108-12 PubMed ID: 22440426, DOI: 10.1016/j.jcct.2012.02.003.
  • Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography.Ghafourian K, Younes D, Simprini LA, Weigold WG, Weissman G, Taylor AJ. Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography. JACC. Cardiovascular Imaging 2012, 5: 589-95 PubMed ID: 22698527, DOI: 10.1016/j.jcmg.2011.12.022.
  • Nonobstructive coronary artery disease as detected by 64-detector row cardiac computed tomographic angiography is associated with increased left ventricular mass.Lin FY, Nicolo D, Devereux RB, Labounty TM, Dunning A, Gomez M, Koduru S, Choi JH, Weinsaft JW, Simprini LA, Callister TQ, Shaw LJ, Berman DS, Min JK. Nonobstructive coronary artery disease as detected by 64-detector row cardiac computed tomographic angiography is associated with increased left ventricular mass. Journal Of Cardiovascular Computed Tomography 2011, 5: 158-64 PubMed ID: 21376693, DOI: 10.1016/j.jcct.2011.01.006.
  • Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism.Engelhardt TC, Taylor AJ, Simprini LA, Kucher N. Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism. Thrombosis Research 2011, 128: 149-54 PubMed ID: 21641020, DOI: 10.1016/j.thromres.2011.05.014.
  • The right sided great vessels by cardiac multidetector computed tomography: normative reference values among healthy adults free of cardiopulmonary disease, hypertension, and obesity.Lin FY, Devereux RB, Roman MJ, Meng J, Jow VM, Simprini L, Jacobs A, Weinsaft JW, Shaw LJ, Berman DS, Callister TQ, Min JK. The right sided great vessels by cardiac multidetector computed tomography: normative reference values among healthy adults free of cardiopulmonary disease, hypertension, and obesity. Academic Radiology 2009, 16: 981-7 PubMed ID: 19394871, DOI: 10.1016/j.acra.2009.02.013.
  • Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States population groups.Baldassarre LA, Steiner NK, Jones P, Tang T, Slack R, Ng J, Hartzman RJ, Hurley CK. Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States population groups. Tissue Antigens 2003, 61: 249-52 PubMed ID: 12694574, DOI: 10.1034/j.1399-0039.2003.00018.x.
  • Seventeen novel HLA-A alleles.Steiner NK, Rizzo M, Bradshaw D, Baldassarre L, Jones P, Koester R, Ng J, Hartzman RJ, Hurley CK. Seventeen novel HLA-A alleles. Tissue Antigens 2003, 62: 256-8 PubMed ID: 12956880, DOI: 10.1034/j.1399-0039.2003.00090.x.
  • Twenty-five novel HLA-B alleles.Steiner NK, Gans C, Baldassarre L, Bradshaw D, Rizzo M, Divekar S, Koester R, Ng J, Hartzman RJ, Hurley CK. Twenty-five novel HLA-B alleles. Tissue Antigens 2003, 62: 263-6 PubMed ID: 12956882, DOI: 10.1034/j.1399-0039.2003.00095.x.
  • Novel HLA-B alleles formed by an inter-locus recombination with HLA-C, HLA-B*0713 and B*6702.Steiner NK, Baldassarre L, Koester R, Ng J, Hartzman RJ, Hurley CK. Novel HLA-B alleles formed by an inter-locus recombination with HLA-C, HLA-B*0713 and B*6702. Tissue Antigens 2002, 59: 148-50 PubMed ID: 12028546, DOI: 10.1034/j.1399-0039.2002.590215.x.
  • Novel HLA-B alleles associated with antigens in the 8C CREG.Steiner NK, Gans CP, Kosman C, Baldassarre LA, Edson S, Jones PF, Rizzuto G, Pimtanothai N, Koester R, Mitton W, Ng J, Hartzman RJ, Hurley CK. Novel HLA-B alleles associated with antigens in the 8C CREG. Tissue Antigens 2001, 57: 373-5 PubMed ID: 11380951, DOI: 10.1034/j.1399-0039.2001.057004373.x.
  • Twenty-nine new HLA-B alleles associated with antigens in the 5C CREG.Steiner NK, Kosman C, Jones PF, Gans CP, Rodriguez-Marino SG, Rizzuto G, Baldassarre LA, Edson S, Koester R, Sese D, Mitton W, Ng J, Hartzman RJ, Hurley CK. Twenty-nine new HLA-B alleles associated with antigens in the 5C CREG. Tissue Antigens 2001, 57: 481-5 PubMed ID: 11556976, DOI: 10.1034/j.1399-0039.2001.057005481.x.
  • Cardiovascular disease in women: insights from magnetic resonance imaging.Bucciarelli-Ducci C, Ostenfeld E, Baldassarre LA, Ferreira VM, Frank L, Kallianos K, Raman SV, Srichai MB, McAlindon E, Mavrogeni S, Ntusi NAB, Schulz-Menger J, Valente AM, Ordovas KG. Cardiovascular disease in women: insights from magnetic resonance imaging. Journal Of Cardiovascular Magnetic Resonance : Official Journal Of The Society For Cardiovascular Magnetic Resonance 2020, 22: 71 PubMed ID: 32981527, PMCID: PMC7520984, DOI: 10.1186/s12968-020-00666-4.
  • Cardiac Biventricular Metastasis From Renal Cell Carcinoma.Latifi AN, Ibe U, Arbune A, Kluger H, Baldassarre LA. Cardiac Biventricular Metastasis From Renal Cell Carcinoma. Cure¯us 2020, 12: e10870 PubMed ID: 33178523, PMCID: PMC7652367, DOI: 10.7759/cureus.10870.
  • Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils.Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. Journal Of The National Cancer Institute 2021, 113: 513-522 PubMed ID: 33179744, PMCID: PMC7717327, DOI: 10.1093/jnci/djaa177.
  • Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey.Sadler D, DeCara JM, Herrmann J, Arnold A, Ghosh AK, Abdel-Qadir H, Yang EH, Szmit S, Akhter N, Leja M, Silva CMPDC, Raikhelkar J, Brown SA, Dent S, O'Quinn R, Thuny F, Moudgil R, Raez LE, Okwuosa T, Daniele A, Bauer B, Kondapalli L, Ismail-Khan R, Lax J, Blaes A, Nahleh Z, Elson L, Baldassarre LA, Zaha V, Rao V, Lara DS, Skurka K. Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey. Cardio-oncology (London, England) 2020, 6: 28 PubMed ID: 33292763, PMCID: PMC7691954, DOI: 10.1186/s40959-020-00085-5.
  • Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity.Higgins AY, Arbune A, Soufer A, Ragheb E, Kwan JM, Lamy J, Henry M, Cuomo JR, Charifa A, Gallegos C, Hull S, Coviello JS, Bader AS, Peters DC, Huber S, Mojibian HR, Sinusas AJ, Kluger H, Baldassarre LA. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. PloS One 2021, 16: e0246764 PubMed ID: 33606757, PMCID: PMC7895343, DOI: 10.1371/journal.pone.0246764.
  • Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).Ordovas KG, Baldassarre LA, Bucciarelli-Ducci C, Carr J, Fernandes JL, Ferreira VM, Frank L, Mavrogeni S, Ntusi N, Ostenfeld E, Parwani P, Pepe A, Raman SV, Sakuma H, Schulz-Menger J, Sierra-Galan LM, Valente AM, Srichai MB. Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR). Journal Of Cardiovascular Magnetic Resonance : Official Journal Of The Society For Cardiovascular Magnetic Resonance 2021, 23: 52 PubMed ID: 33966639, PMCID: PMC8108343, DOI: 10.1186/s12968-021-00746-z.
  • Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation.Guha A, Caraballo C, Jain P, Miller PE, Owusu-Guha J, Clark KAA, Velazquez EJ, Ahmad T, Baldassarre LA, Addison D, Weintraub NL, Desai NR. Outcomes in patients with anthracycline-induced cardiomyopathy undergoing left ventricular assist devices implantation. ESC Heart Failure 2021, 8: 2866-2875 PubMed ID: 33982867, PMCID: PMC8318466, DOI: 10.1002/ehf2.13362.
  • Fat-saturated dark-blood cardiac T2 mapping in a single breath-hold.Hu C, Huber S, Nguyen V, Baldassarre L, Mojibian H, Peters D. Fat-saturated dark-blood cardiac T2 mapping in a single breath-hold. Magnetic Resonance Imaging 2021, 81: 24-32 PubMed ID: 34044065, DOI: 10.1016/j.mri.2021.05.004.
  • Aortic Delamination-A Possible Precursor of Impending Catastrophe.Saeyeldin A, Zafar MA, Baldassarre LA, Mojibian H, Ziganshin BA, Mukherjee SK, Elefteriades JA. Aortic Delamination-A Possible Precursor of Impending Catastrophe. The International Journal Of Angiology : Official Publication Of The International College Of Angiology, Inc 2021, 30: 160-164 PubMed ID: 34054275, PMCID: PMC8159620, DOI: 10.1055/s-0040-1718546.
  • Adverse thrombo-embolic events with newer tyrosine kinase inhibitors: a call to action for better risk stratification and monitoring.Hussain Z, Baldassarre L, Dent S, Weintraub NL, Guha A. Adverse thrombo-embolic events with newer tyrosine kinase inhibitors: a call to action for better risk stratification and monitoring. European Journal Of Preventive Cardiology 2021 PubMed ID: 34219160, DOI: 10.1093/eurjpc/zwab055.
  • Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma.Kwan JM, Odanovic N, Arbune A, Higgins A, Henry M, Greif D, Foss F, Baldassarre LA. Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma. JACC. Case Reports 2021, 3: 1018-1023 PubMed ID: 34317676, PMCID: PMC8311348, DOI: 10.1016/j.jaccas.2021.04.001.
  • Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization.O'Quinn R, Ferrari VA, Daly R, Hundley G, Baldassarre LA, Han Y, Barac A, Arnold A. Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization. JACC. CardioOncology 2021, 3: 191-200 PubMed ID: 34396324, PMCID: PMC8352183, DOI: 10.1016/j.jaccao.2021.04.011.
  • Rationale and proposed framework for shared decision making in cardio-oncology.Hull SC, Soufer A, Spatz ES, Baldassarre LA. Rationale and proposed framework for shared decision making in cardio-oncology. Cardio-oncology (London, England) 2021, 7: 30 PubMed ID: 34425913, PMCID: PMC8380868, DOI: 10.1186/s40959-021-00118-7.
  • Are cardiology fellows receiving enough basic level I cardiovascular computed tomography education during their general fellowship training? Insights from a needs assessment survey at an academic medical center.Hur DJ, Meadows JL, Baldassarre LA, Mojibian HR, Villines TC, Windish DM. Are cardiology fellows receiving enough basic level I cardiovascular computed tomography education during their general fellowship training? Insights from a needs assessment survey at an academic medical center. Journal Of Cardiovascular Computed Tomography 2021 PubMed ID: 34600865, DOI: 10.1016/j.jcct.2021.09.005.
  • Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers.Peters DC, Lamy J, Sinusas AJ, Baldassarre LA. Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers. European Heart Journal Cardiovascular Imaging 2021, 23: 14-30 PubMed ID: 34718484, PMCID: PMC8685602, DOI: 10.1093/ehjci/jeab221.
  • Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience.Batra A, Patel B, Addison D, Baldassarre LA, Desai N, Weintraub N, Deswal A, Hussain Z, Brown SA, Ganatra S, Agarwala V, Parikh PM, Fradley M, Ghosh A, Guha A. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart 2021, 8 PubMed ID: 34952868, PMCID: PMC8710909, DOI: 10.1136/openhrt-2021-001849.

Clinical Trials

ConditionsStudy Title
Unknown Sites; Urinary BladderAdvanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis
Edit Profile